Glucaric acid

Glucaric acid is a lipid of Fatty Acyls (FA) class. Glucaric acid is associated with abnormalities such as Consumption-archaic term for TB and furuncle. The involved functions are known as Oxidation, Mutation, Process, Cell Growth and Anabolism. Glucaric acid often locates in BL21, Clone and host. The associated genes with Glucaric acid are MIOX gene, ISYNA1 gene, Genome and Candidate Disease Gene. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of Glucaric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Glucaric acid?

Glucaric acid is suspected in and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Glucaric acid

MeSH term MeSH ID Detail
Blood Loss, Surgical D016063 6 associated lipids
Anemia, Iron-Deficiency D018798 6 associated lipids
Thrombophlebitis D013924 6 associated lipids
Mycobacterium Infections D009164 7 associated lipids
Jaundice, Neonatal D007567 7 associated lipids
Postoperative Hemorrhage D019106 7 associated lipids
Leprosy D007918 8 associated lipids
Renal Insufficiency, Chronic D051436 9 associated lipids
Ascorbic Acid Deficiency D001206 9 associated lipids
Hearing Disorders D006311 10 associated lipids
Per page 10 20 50 100 | Total 85

PubChem Associated disorders and diseases

What pathways are associated with Glucaric acid

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Glucaric acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Glucaric acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Glucaric acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Glucaric acid?

There are no associated biomedical information in the current reference collection.

What genes are associated with Glucaric acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Glucaric acid?

Knock-out

Knock-out are used in the study 'Evolution-guided optimization of biosynthetic pathways.' (Raman S et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Glucaric acid

Download all related citations
Per page 10 20 50 100 | Total 1061
Authors Title Published Journal PubMed Link
Sricholpech M et al. Lysyl hydroxylase 3-mediated glucosylation in type I collagen: molecular loci and biological significance. 2012 J. Biol. Chem. pmid:22573318
Wyffels L et al. Detection of myocardial ischemia-reperfusion injury using a fluorescent near-infrared zinc(II)-dipicolylamine probe and 99mTc glucarate. 2012 Mol Imaging pmid:22554483
Borchard G et al. Nanoparticle iron medicinal products - Requirements for approval of intended copies of non-biological complex drugs (NBCD) and the importance of clinical comparative studies. 2012 Regul. Toxicol. Pharmacol. pmid:22951348
Smith AA et al. The CanOE strategy: integrating genomic and metabolic contexts across multiple prokaryote genomes to find candidate genes for orphan enzymes. 2012 PLoS Comput. Biol. pmid:22693442
De Sousa A and Kalra G Drug therapy of attention deficit hyperactivity disorder: current trends. 2012 Mens Sana Monogr pmid:22654382
Ceretta LB et al. Increased oxidative stress and imbalance in antioxidant enzymes in the brains of alloxan-induced diabetic rats. 2012 Exp Diabetes Res pmid:22645603
Yamamoto S et al. Fibroblast growth factor 23-related osteomalacia caused by the prolonged administration of saccharated ferric oxide. 2012 Intern. Med. pmid:22975552
Ernst MC et al. Disruption of the chemokine-like receptor-1 (CMKLR1) gene is associated with reduced adiposity and glucose intolerance. 2012 Endocrinology pmid:22186410
Kamanna VS et al. Iron sucrose promotes endothelial injury and dysfunction and monocyte adhesion/infiltration. 2012 Am. J. Nephrol. pmid:22212390
Stein J et al. Clinical case reports raise doubts about the therapeutic equivalence of an iron sucrose similar preparation compared with iron sucrose originator. 2012 Curr Med Res Opin pmid:22181342
Rashid K et al. Protective role of D-saccharic acid-1,4-lactone in alloxan induced oxidative stress in the spleen tissue of diabetic rats is mediated by suppressing mitochondria dependent apoptotic pathway. 2012 Free Radic. Res. pmid:22239106
Ichii H et al. Iron sucrose impairs phagocytic function and promotes apoptosis in polymorphonuclear leukocytes. 2012 Am. J. Nephrol. pmid:22722756
Pfenniger A et al. Safety and efficacy of high-dose intravenous iron carboxymaltose vs. iron sucrose for treatment of postpartum anemia. 2012 J Perinat Med pmid:22752771
da Silva Krause M et al. Physiological concentrations of interleukin-6 directly promote insulin secretion, signal transduction, nitric oxide release, and redox status in a clonal pancreatic β-cell line and mouse islets. 2012 J. Endocrinol. pmid:22761278
Galindo P et al. Glucuronidated quercetin lowers blood pressure in spontaneously hypertensive rats via deconjugation. 2012 PLoS ONE pmid:22427863
Conner TA et al. Effect of intravenous vitamin C on cytokine activation and oxidative stress in end-stage renal disease patients receiving intravenous iron sucrose. 2012 Biometals pmid:22706571
Araki T et al. Clinical efficacy of two forms of intravenous iron--saccharated ferric oxide and cideferron--for iron deficiency anemia. 2012 Pharmazie pmid:23346769
Isnardi V et al. Is [(99m)Tc]glucarate uptake mediated by fructose transporter GLUT-5? 2012 Nucl. Med. Biol. pmid:23084044
Xia B et al. A novel local recycling mechanism that enhances enteric bioavailability of flavonoids and prolongs their residence time in the gut. 2012 Mol. Pharm. pmid:23033922
Smith TN et al. Modifications in the nitric acid oxidation of D-glucose. 2012 Carbohydr. Res. pmid:22285512
Kowalczyk M et al. Ferumoxytol: a new era of iron deficiency anemia treatment for patients with chronic kidney disease. 2011 Nov-Dec J. Nephrol. pmid:21956770
Bhattacharya S et al. Prophylactic role of D-Saccharic acid-1,4-lactone in tertiary butyl hydroperoxide induced cytotoxicity and cell death of murine hepatocytes via mitochondria-dependent pathways. 2011 Nov-Dec J. Biochem. Mol. Toxicol. pmid:21538728
Adhikary L and Acharya S Efficacy of IV iron compared to oral iron for increment of haemoglobin level in anemic chronic kidney disease patients on erythropoietin therapy. 2011 Jul-Sep JNMA J Nepal Med Assoc pmid:22922860
Moorani KN and Asim S Parenteral iron sucrose in iron deficiency anaemia of paediatric chronic kidney disease. 2011 Jul-Sep J Ayub Med Coll Abbottabad pmid:23272434
Yetman AT and Everitt MD The role of iron deficiency in protein-losing enteropathy following the Fontan procedure. 2011 Jul-Aug Congenit Heart Dis pmid:21392262
Centeno DC et al. Malate plays a crucial role in starch metabolism, ripening, and soluble solid content of tomato fruit and affects postharvest softening. 2011 Plant Cell pmid:21239646
Walther J et al. Hot transcriptomics. 2011 Archaea pmid:21350598
Denton TT et al. Characterization of D-glucaric acid using NMR, X-ray crystal structure, and MM3 molecular modeling analyses. 2011 Carbohydr. Res. pmid:22015400
Bhattacharya S et al. D-saccharic acid-1,4-lactone ameliorates alloxan-induced diabetes mellitus and oxidative stress in rats through inhibiting pancreatic β-cells from apoptosis via mitochondrial dependent pathway. 2011 Toxicol. Appl. Pharmacol. pmid:21982801
Aspuru K et al. Optimal management of iron deficiency anemia due to poor dietary intake. 2011 Int J Gen Med pmid:22114518
Toblli JE et al. Evaluation of toxicity and oxidative stress induced by intravenous iron isomaltoside 1000 in a nonclinical model. 2011 Arzneimittelforschung pmid:22164963
Menendez C et al. Vascular deconjugation of quercetin glucuronide: the flavonoid paradox revealed? 2011 Mol Nutr Food Res pmid:22144045
Di Nocera PP et al. Genome organization of epidemic Acinetobacter baumannii strains. 2011 BMC Microbiol. pmid:21985032
Lv YK et al. Poly[dimethyl-ammonium [aquadi-μ(2)-oxalato-yttriate(III)] trihydrate]. 2011 Acta Crystallogr Sect E Struct Rep Online pmid:21836844
Cheng D et al. A brief evaluation of tumor imaging in mice with 99mTc-glucarate including a comparison with 18F-FDG. 2011 Curr Radiopharm pmid:22191610
Lv YK et al. Poly[dimethyl-ammonium [aquadi-μ(2)-oxalato-samarate(III)] trihydrate]. 2011 Acta Crystallogr Sect E Struct Rep Online pmid:21836843
Toyokuni S Mysterious link between iron overload and CDKN2A/2B. 2011 J Clin Biochem Nutr pmid:21297911
Nasir A et al. Management of iron deficiency anaemia in gynaecological patients at Jinnah Postgraduate Medical Centre, Karachi. 2011 J Pak Med Assoc pmid:22356035
Wada Y et al. [Case report; A case of FGF23-related hypophosphatemic osteomalacia caused by long-term administration of saccharated ferric oxide]. 2011 Nippon Naika Gakkai Zasshi pmid:22175146
Lawrence MC et al. Calcineurin/nuclear factor of activated T cells and MAPK signaling induce TNF-{alpha} gene expression in pancreatic islet endocrine cells. 2011 J. Biol. Chem. pmid:21059644
Kolodziejczyk J et al. In vitro study of the antioxidative properties of the glucose derivatives against oxidation of plasma components. 2011 J. Physiol. Biochem. pmid:21086198
Vu'o'ng Lê B et al. New rat models of iron sucrose-induced iron overload. 2011 Exp. Biol. Med. (Maywood) pmid:21685238
Kowalczyk MC et al. Modulation of biomarkers related to tumor initiation and promotion in mouse skin by a natural β-glucuronidase inhibitor and its precursors. 2011 Oncol. Rep. pmid:21687956
Evstatiev R et al. FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease. 2011 Gastroenterology pmid:21699794
Solak Y et al. Comparison of adverse-event profiles of intravenous low-molecular-weight iron dextran and iron sucrose in peritoneal dialysis patients. 2011 Ren Fail pmid:21401355
Gambini JP et al. Evaluation of 99mTc-glucarate as a breast cancer imaging agent in a xenograft animal model. 2011 Nucl. Med. Biol. pmid:21315281
Takeda Y et al. Effect of intravenous saccharated ferric oxide on serum FGF23 and mineral metabolism in hemodialysis patients. 2011 Am. J. Nephrol. pmid:21502756
Meier T et al. Physicochemical and toxicological characterization of a new generic iron sucrose preparation. 2011 Arzneimittelforschung pmid:21428246
Agarwal R et al. Proteinuria induced by parenteral iron in chronic kidney disease--a comparative randomized controlled trial. 2011 Clin J Am Soc Nephrol pmid:20876669
Auerbach M Should intravenous iron be upfront therapy for iron deficiency anemia? 2011 Pediatr Blood Cancer pmid:21298731
Crary SE et al. Intravenous iron sucrose for children with iron deficiency failing to respond to oral iron therapy. 2011 Pediatr Blood Cancer pmid:21298748
Ibert M et al. Evidence of benzilic rearrangement during the electrochemical oxidation of D-glucose to D-glucaric acid. 2011 Carbohydr. Res. pmid:21269605
Vanderford NL The role of MafA in regulating cytokine expression in pancreatic beta cells. 2011 J. Biol. Chem. pmid:21239506
Fenwick S and Peebles G Total dose infusion of intravenous iron in patients with chronic kidney disease receiving haemodialysis. 2011 J Ren Care pmid:21288317
Pai AB et al. Non-transferrin bound iron, cytokine activation and intracellular reactive oxygen species generation in hemodialysis patients receiving intravenous iron dextran or iron sucrose. 2011 Biometals pmid:21229380
Krafft A and Breymann C Iron sucrose with and without recombinant erythropoietin for the treatment of severe postpartum anemia: a prospective, randomized, open-label study. 2011 J. Obstet. Gynaecol. Res. pmid:21159035
Stefánsson BV et al. Acute oxidative stress following intravenous iron injection in patients on chronic hemodialysis: a comparison of iron-sucrose and iron-dextran. 2011 Nephron Clin Pract pmid:21196770
Atalay H et al. Safety profiles of total dose infusion of low-molecular-weight iron dextran and high-dose iron sucrose in renal patients. 2011 Hemodial Int pmid:21564503
Serrano-Trenas JA et al. Role of perioperative intravenous iron therapy in elderly hip fracture patients: a single-center randomized controlled trial. 2011 Transfusion pmid:20630042
Malovrh M et al. The influence of need-based, continuous, low-dose iron replacement on hemoglobin levels in hemodialysis patients treated with erythropoiesis-stimulating agents. 2011 Artif Organs pmid:20618233
Rottembourg J et al. Do two intravenous iron sucrose preparations have the same efficacy? 2011 Nephrol. Dial. Transplant. pmid:21355067
Kim Y et al. Combination of erythritol and fructose increases gastrointestinal symptoms in healthy adults. 2011 Nutr Res pmid:22118754
Bailie GR et al. Differences in spontaneously reported hypersensitivity and serious adverse events for intravenous iron preparations: comparison of Europe and North America. 2011 Arzneimittelforschung pmid:21755809
Gomollón F and Gisbert JP IBD: Intravenous iron in IBD--what's the best preparation? 2011 Nat Rev Gastroenterol Hepatol pmid:21788975
Bisbe E et al. A multicentre comparative study on the efficacy of intravenous ferric carboxymaltose and iron sucrose for correcting preoperative anaemia in patients undergoing major elective surgery. 2011 Br J Anaesth pmid:21841061
Toblli JE et al. Assessment of the extent of oxidative stress induced by intravenous ferumoxytol, ferric carboxymaltose, iron sucrose and iron dextran in a nonclinical model. 2011 Arzneimittelforschung pmid:21899208
Goggin MM et al. Analysis of total and transferrin-bound iron in human serum for pharmacokinetic studies of iron-sucrose formulations. 2011 Bioanalysis pmid:21877893
Ruiz JC et al. Evidence for reductive genome evolution and lateral acquisition of virulence functions in two Corynebacterium pseudotuberculosis strains. 2011 PLoS ONE pmid:21533164
Rodionov DA et al. Genomic encyclopedia of sugar utilization pathways in the Shewanella genus. 2010 BMC Genomics pmid:20836887
Chaudhuri RR et al. Complete genome sequence and comparative metabolic profiling of the prototypical enteroaggregative Escherichia coli strain 042. 2010 PLoS ONE pmid:20098708
Laidlaw M et al. Effects of a breast-health herbal formula supplement on estrogen metabolism in pre- and post-menopausal women not taking hormonal contraceptives or supplements: a randomized controlled trial. 2010 Breast Cancer (Auckl) pmid:21234288
Lippow SM et al. Engineering enzyme specificity using computational design of a defined-sequence library. 2010 Chem. Biol. pmid:21168766
Suzuki E et al. Identification of valproic acid glucuronide hydrolase as a key enzyme for the interaction of valproic acid with carbapenem antibiotics. 2010 Drug Metab. Dispos. pmid:20551238
Hoffman K et al. Exposure to polyfluoroalkyl chemicals and attention deficit/hyperactivity disorder in U.S. children 12-15 years of age. 2010 Environ. Health Perspect. pmid:20551004
Sienkiewicz-Porzucek A et al. Mild reductions in mitochondrial NAD-dependent isocitrate dehydrogenase activity result in altered nitrate assimilation and pigmentation but do not impact growth. 2010 Mol Plant pmid:20035036
Sturm B et al. In vitro study on the effects of iron sucrose, ferric gluconate and iron dextran on redox-active iron and oxidative stress. 2010 Arzneimittelforschung pmid:20712137
Swarnalatha G et al. Oxidative stress in hemodialysis patients receiving intravenous iron therapy and the role of N-acetylcysteine in preventing oxidative stress. 2010 Saudi J Kidney Dis Transpl pmid:20814119
Bager P and Dahlerup JF The health care cost of intravenous iron treatment in IBD patients depends on the economic evaluation perspective. 2010 J Crohns Colitis pmid:21122539
Froessler B and Papendorf D Intravenous iron sucrose--an effective and attractive modality for perioperative anaemia management. 2010 Anaesth Intensive Care pmid:20865896
Saluk-Juszczak J A comparative study of antioxidative activity of calcium-D-glucarate, sodium-D-gluconate and D-glucono-1,4-lactone in a human blood platelet model. 2010 Platelets pmid:20873960
Dangsuwan P and Manchana T Blood transfusion reduction with intravenous iron in gynecologic cancer patients receiving chemotherapy. 2010 Gynecol. Oncol. pmid:20051288
Lajolo C et al. Calcium glucarate inhibits DMBA-induced oral carcinogenesis in the hamster: histomorphometric evaluation. 2010 Anticancer Res. pmid:20393005
Wu CJ et al. Comparison of parenteral iron sucrose and ferric chloride during erythropoietin therapy of haemodialysis patients. 2010 Nephrology (Carlton) pmid:20377770
McMahon LP et al. Maintenance of elevated versus physiological iron indices in non-anaemic patients with chronic kidney disease: a randomized controlled trial. 2010 Nephrol. Dial. Transplant. pmid:19906658
Stancu S et al. Can the response to iron therapy be predicted in anemic nondialysis patients with chronic kidney disease? 2010 Clin J Am Soc Nephrol pmid:20019121
Rombouts K and Marra F Molecular mechanisms of hepatic fibrosis in non-alcoholic steatohepatitis. 2010 Dig Dis pmid:20460917
Rangel EB et al. Labile plasma iron generation after intravenous iron is time-dependent and transitory in patients undergoing chronic hemodialysis. 2010 Ther Apher Dial pmid:20438541
Tampi R Delayed adverse reactions to iron polymaltose and iron sucrose. 2010 Intern Med J pmid:20446963
Garcia-Fernandez N et al. Randomized clinical trial on acute effects of i.v. iron sucrose during haemodialysis. 2010 Nephrology (Carlton) pmid:20470276
Firoz BF et al. Eosinophilic fasciitis secondary to intravenous iron infusions. 2010 Dermatol. Online J. pmid:20492822
Gupta A et al. Response to iron sucrose in dialysis patients sensitive to iron dextran. 2010 Saudi J Kidney Dis Transpl pmid:20587886
Zhang ZW et al. The plastid hexokinase pHXK: a node of convergence for sugar and plastid signals in Arabidopsis. 2010 FEBS Lett. pmid:20650273
Okada DR et al. 99mTc-glucarate kinetics differentiate normal, stunned, hibernating, and nonviable myocardium in a perfused rat heart model. 2010 Eur. J. Nucl. Med. Mol. Imaging pmid:20652807
Kell DB Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples. 2010 Arch. Toxicol. pmid:20967426
Chinnappa S and Bhandari S Influence of intravenous iron therapy on novel markers of iron deficiency. 2010 Int J Artif Organs pmid:20593351
Do PT et al. The influence of fruit load on the tomato pericarp metabolome in a Solanum chmielewskii introgression line population. 2010 Plant Physiol. pmid:20841452
Ranganathan P and Pramesh CS Letter 1: Randomized clinical trial of preoperative intravenous iron sucrose to reduce blood transfusion in anaemic patients after colorectal cancer surgery (Br J Surg 2009; 96: 1122-1128). 2010 Br J Surg pmid:20069595
Kowalczyk MC et al. Synergistic effects of combined phytochemicals and skin cancer prevention in SENCAR mice. 2010 Cancer Prev Res (Phila) pmid:20103723
Hu Q et al. Homozygous deletion of CDKN2A/2B is a hallmark of iron-induced high-grade rat mesothelioma. 2010 Lab. Invest. pmid:20065947
Yang Z et al. Symbiosis between microorganisms from kombucha and kefir: Potential significance to the enhancement of kombucha function. 2010 Appl. Biochem. Biotechnol. pmid:18810658